Skip to main content
SpringerLink
Log in

Long QT syndrome under mitotane therapy

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005, 12: 667–80.

    Article  PubMed  CAS  Google Scholar 

  2. Ilias I, Alevizaki M, Philippou G, Anastasiou E, Souvatzoglou A. Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane. J Endocrinol Invest 2001, 24: 532–5.

    Article  PubMed  CAS  Google Scholar 

  3. Pohlink C, Tannapfel A, Eichfeld U, et al. Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? J Endocrinol Invest 2004, 27: 565–9.

    Article  PubMed  CAS  Google Scholar 

  4. Jensen BL, Caldwell MW, French LG, Briggs DG. Toxicity, ultrastructural effects, and metabolic studies with 1-(o-chlo-rophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane(o,p’-DDD) and its methyl analog in the guinea pig and rat. Toxicol Appl Pharmacol 1987, 87: 1–9.

    Article  PubMed  CAS  Google Scholar 

  5. Lanser JB, van Seters AP, Moolenaar AJ, Haak HR, Bollen EL. Neuropsychologic and neurologic side effects of mitotane and reversibility of symptoms. J Clin Oncol 1992, 10: 1504.

    PubMed  CAS  Google Scholar 

  6. Bollen E, Lanser JB. Reversible mental deterioration and neurological disturbances with o,p’-DDD therapy. Clin Neurol Neurosurg 1992, 94 (Suppl.): S49–51.

    Article  PubMed  Google Scholar 

  7. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004, 350: 1013–22.

    Article  PubMed  CAS  Google Scholar 

  8. Kannankeril PJ, Roden DM, Norris KJ, Whalen SP, George AL, Murray KT. Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm 2005, 2: 134–40.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Medical Center of Leipzig, Germany

    R. U. Pliquett, U. Eichfeld, M. Stumvoll & C. A. Koch

  2. University of Mississippi Medical Center, Jackson, MS, USA

    R. U. Pliquett, U. Eichfeld, M. Stumvoll & C. A. Koch

Authors
  1. R. U. Pliquett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Eichfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stumvoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. A. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pliquett, R.U., Eichfeld, U., Stumvoll, M. et al. Long QT syndrome under mitotane therapy. J Endocrinol Invest 30, 167–168 (2007). https://doi.org/10.1007/BF03347417

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347417

Keywords

Search

Navigation